SEC Form 4 · accession 0001140361-26-023988
Vericel Corp · VCEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Mark Hopper
Officer — Chief Medical Officer
Period of report
Jun 2, 2026
Accepted (ET)
Jun 4, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000887359
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 2, 2026 | M | 4,375 | $16.66 | A | 80,128 | D | |
| Common StockF2,F1 | Jun 2, 2026 | S | 4,375 | $35.00 | D | 75,753 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $16.66 | Jun 2, 2026 | M | 4,375 | A | — | Feb 6, 2029 | Common Stock | 4,375 | 1,625 | D |
Explanation of responses
- F1These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F2The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.
- F3These options, representing the right to purchase 26,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted.